News & Perspectives
Discover the latest news, research, expert perspectives and
media from across DXY.

DXY Insight Database at CPIC 2026: AI Drug Discovery Enters the Era of Asset Realization
At the inaugural China Pharmaceutical Innovation Conference (CPIC China 2026), DXY Insight examined how AI drug discovery is moving beyond technological exploration toward clinical validation, commercial partnerships, and the creation of tangible pharmaceutical assets.

Conquering the "Silver Tsunami": Insight Examines the Landscape and Trends of Innovative Drug R&D for Alzheimer's Disease at ICNS 2026
What does the “Silver Tsunami” mean for the future of Alzheimer’s drug development? At ICNS 2026, DXY Insight Database explored key trends shaping the Alzheimer’s drug R&D landscape, from disease-modifying therapies and patient access to earlier diagnosis, multi-target approaches, and market adoption.

DXY Insight Database Redefining Boundaries, Building a Shared Ecosystem: Insight InCity Brings Pharmaceutical BD Leaders Together in Beijing
On August 27, DXY Insight Database hosted the Beijing edition of Insight InCity, bringing together leaders from multinational pharmaceutical companies, innovative biotech and pharma companies, investment institutions, and industry partners to explore the evolving pharma BD landscape.

As AI Enters Medical Decision-Making, Where Will Healthcare Companies Find New Growth Opportunities?
DXY Executive Forum Explores Shifts in Physician Decision-Making and the Future of Healthcare Growth

DXY Founder Stanley Tiantian Li: Turning Physicians’ Needs into a Compass for Drug R&D
At BIOHK 2026, DXY Founder and Chairman Stanley Tiantian Li shared his perspective on how physicians could become true partners in drug R&D, and how clinical needs could help inform new directions for innovation.

DXY Forms Strategic Partnership with Johnson & Johnson Innovative Medicine China to Explore a New Digital Future for Healthcare
DXY and Johnson & Johnson Innovative Medicine China have signed a strategic partnership agreement.

